Enhancing Stemness of Polyclonal T Cells to Improve Anti-Tumor Activity

Time: 9:30 am
day: Day One


• Yielding highly effective polyclonal T cell products by utilizing next generation strategies including gene editing

• Enriching for tumor-specific T cell clonotypes in clinical T cell products to improve therapeutic efficacy

• Emerging approaches to maximize clinical utility of TIL products